NEW YORK (GenomeWeb News) – Response Biomedical said today that revenues in the third quarter increased 69 percent year over year.

Revenues in the quarter reached C$2.7 million (US$2.7 million), up from C$1.6 million a year ago. The firm said that cardiovascular sales rose 86 percent to C$2.6 million from C$1.4 million a year ago, driven primarily by business in China and Europe.

Its infectious disease, Bio-defense, and Environmental business, however, declined to C$85,000 from C$124,000 a year ago, a 31 percent drop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.